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Abstract: We examined whether trained women exhibit similar cardiovascular and cardiac baroreflex
alterations after a half-marathon compared to men. Thirteen women (39.1 ± 9.3 years; 165 ± 6 cm;
58.2 ± 7.5 kg; maximal aerobic speed (MAS): 13.7 ± 2.2 km·h−1) and 12 men (45.7 ± 10.5 years;
178 ± 7 cm; 75.0 ± 8.3 kg; MAS: 15.8 ± 2.2 km·h−1) ran an official half-marathon. Before and 60-min
after, cardiovascular variables, parasympathetic (heart rate variability analysis) modulation and
cardiac baroreflex function (transfer function and sequence analyses) were assessed during supine
rest and a squat-stand test. Running performance was slower in women than in men (120 ± 19 vs.
104 ± 14 min for women and men, respectively). However, when expressed as a percentage of MAS,
it was similar (78.1 ± 4.6% and 78.2 ± 5.4% of MAS for women and men, respectively). Before the
run, women exhibited lower mean blood pressure (BP), cardiac output (CO) and stroke volume (SV)
compared to men, together with higher parasympathetic indexes. After the race, parasympathetic
indexes decreased in both sexes, but remained higher in women. Reduced SV, systolic BP and cardiac
baroreflex were observed in men but not in women. Contrary to men, a competitive half-marathon
did not trigger post-exercise hypotension and a reduced cardiac baroreflex in women.
Keywords: baroreflex; sympathetic; parasympathetic; squat stand test; half-marathon; sex; running
1. Introduction
Cardiovascular disease (CVD) is the leading cause of mortality amongst women worldwide [1,2],
making the reduction of CVD risk a crucial factor in reducing mortality [3]. A healthy lifestyle that
reduces the risk of CVD should include at least 150 min per week of moderate-intensity aerobic
exercise, 75 min per week of vigorous-intensity aerobic exercise or an equivalent combination of the
two intensities [4,5].
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Accordingly, women are more and more involved in leisure-time running and competitive running
events, including running races from 5 km to ultramarathons in distance (>42.2 km) [6,7]. Despite the
female sex being well represented in all the different race distances, recent surveys about running event
participation reveal that women make up a greater proportion of participants in shorter distance events
when compared to longer events [8]. For instance, at races in Switzerland, the number of females
completing half marathon is ~12 times higher than marathons [9].
Long-duration and intense physical challenges may reveal cardiac dysfunction that is otherwise
compensated for at rest, and a U-shaped relationship between exercise and cardiac morbidity
exists [5,10]. Fortunately, the overall risk of sudden death during exercise is considered low (between
0.1 and 38/100,000 person-years), and comparable to that of the general population, meaning that 20%
of all sudden death cases are still recorded during exercise [11]. Most deaths can be attributable to
underlying cardiac abnormalities where exercise is a mere trigger for a fatal event rather than the
actual cause of death [11], together with changes in the autonomic nervous system (ANS) activity.
Indeed, dynamic exercise is associated with a shift towards sympathetic dominance during the
exercise and after its cessation [12–14], potentially leading to an increase in susceptibility to sudden
cardiovascular events [15]. In particular, post-exercise recovery (mainly in the first 30 min and especially
after vigorous exercise [16]) is a critical phase for sudden cardiovascular events. This is attributable
to increased sympathetic and decreased parasympathetic nerve activity [17]. Depending on exercise
and individual’s characteristics, complete autonomic recovery may take even longer [18]. Whether a
specific sex-difference in cardiovascular events triggered by exercise is still debated, since studies
both suggest a lower atrial fibrillation risk in women but also an increased risk at lower intensities of
exercise [19]. The ANS responses need additional research as well.
Indeed, it is well established that at rest, young, pre-menopausal women have greater
parasympathetic activity and reduced sympathetic activity [20,21]. This leads to a different
cardiovascular regulation by the ANS with lower resting blood pressure (BP) values in women,
and they tend to experience orthostatic hypotension and fainting more frequently than men [22].
Whether these autonomic differences persist during exercise and into early recovery is unclear and
seems to depend on the training status and the type of exercise. For instance, greater vagal withdrawal
during ramp-type exercise below the anaerobic threshold has been suggested in sedentary women [23].
On the contrary, during an acute supramaximal exercise (Wingate test), a lower sympatho-adrenergic
response has been reported in female compared to male athletes [24]. Paradoxically, after such an
exercise, a greater parasympathetic withdrawal during the recovery was reported in women [25].
Overall, it suggests that despite the fact that women exhibit a more favorable resting autonomic
profile, they experience greater autonomic alterations after a single bout of supramaximal exercise.
Alongside these observations, hemodynamic determinants of post-exercise hypotension (post-exercise
reduction in BP) are likely to differ between sexes and need further investigation especially with intense
exercise involving trained participants [26,27].
However, autonomic and cardiovascular responses to endurance exercise have been poorly
studied in trained women, despite years of recognition that sex influences physiological responses
to exercise. In recent decades, many research groups have pointed out this weakness [28] and it is
essential to further characterize women’s response in this area. Thus, the aim of our study was to
investigate the effect of an acute, competitive endurance exercise bout (21 km run competition) on
cardiovascular and autonomic responses in trained women and men. In accordance with previous
observations made after intense exercise, our hypothesis was that trained women would show greater
alterations in cardiovascular and parasympathetic responses to a half-marathon than trained men.
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2. Materials and Methods
2.1. Participants
This cross-sectional study involved 25 volunteer amateur runners: 13 healthy, non-pregnant,
pre-menopausal women with regular menstruation (menstrual cycle ranges from 25 to 32 days)
and 12 men. Although limited, this sample size is in accordance with previous studies on ANS
using a similar design [25,29–31]. They were recruited within the Run for Science event, hosted by
the University of Verona (Italy) in April 2019 [31]. The inclusion criteria were a history of regular
recreational running training (mean training regimen of 220 min/week) for more than five years
and having previously finished a half-marathon in the previous two years. The presence of disease,
pharmacological treatment, cigarette smoking, alcohol (more than six glasses per week) or coffee (more
than four cups per day) abuse were exclusion criteria determined by standard medical examination.
All participants provided their written informed consent before participating in the experiments.
The study was approved by the local Ethical Committee (Department of Neurosciences, Biomedicine
and Movement Sciences, University of Verona, Verona, Italy; protocol number 165038) and performed
in accordance with the Helsinki Declaration of 1975.
2.2. Study Protocol
Maximal oxygen uptake (
.
VO2max), maximal aerobic speed (MAS) and the speeds associated with the
first (VT1) and second (VT2) ventilatory thresholds were determined by an incremental treadmill running
test at the laboratory, following procedures already described [32]. VT1 and VT2 were determined
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VO2 with a further increase in exercise intensity. Briefly, the protocol test was individualized for
each participant to control the duration of each test (incremental phases lasted 8–12 min). Therefore,
the initial speed was determined by the participant’s capacity, and it was increased by 0.5 km/h every
minute until exhaustion. The running surface slope was kept at a constant +1% throughout the test
(Runrace Technogym, Gambettola, Italy). Oxygen uptake and ventilatory parameters were determined
breath-by-breath using a Cosmed metabolic cart (Quark PFT, Cosmed Rome, Italy).
No more than 15 days later, participants competed in an official half-marathon race certified by the
Italian Track and Field Federation. The day of the race, the weather was sunny, with no wind, the air
temperature was 19 ◦C with 71% humidity (stable throughout the duration of the event). Participants
were instructed to fast for at least 3 h before testing, to refrain from ingesting beverages containing
caffeine and alcohol and not to exercise (beyond normal lifestyle activities) for at least 24 h prior to testing.
To avoid many people reaching the testing station simultaneously, the participants started the race in
waves (from 7:30 to 10:00 a.m.) scheduled based on their individual estimated race time. Before, and 1 h
after the cessation of the exercise, participants in underwear were weighed to the nearest 0.1 kg with a
digital scale (Seca, Hamburg, Germany). Cardiovascular variables, including heart rate (HR), systolic
(SAP) and diastolic (DAP) arterial blood pressures, were then measured continuously (Portapres®;
Finapres Medical System, Amsterdam, The Netherlands) over a 10-min period while the participants lay
in the supine position. Additionally, R-R intervals were measured continuously using a Polar RS800CX
HR monitor (Polar, Kempele, Finland). Resting data were used to obtain spontaneous changes in arterial
blood pressure, R-R interval and baseline steady-state hemodynamics. Cardiovascular parameters were
also collected during repeated squat-stand maneuvers (Squat Stand Test, SST) performed for 5 min with
a duty cycle of a squat held for 10 s followed by 10 s standing [31]. During SST, the participants were
instructed to avoid performing a Valsalva maneuver while standing up.
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2.3. Heart Rate Variability, Baroreflex Sensitivity and Hemodynamic Assessment
The Portapres® device measures arterial pressure using photoplethysmography of the middle
phalanx of the middle finger, which is calibrated to the oscillometrically obtained brachial BP. Arterial
pulse pressure (PP, mmHg) was calculated by subtracting DAP from SAP. The HR/Inter-Beat Interval
(IBI) was derived from the beat-to-beat arterial pressure wave.
The arterial pressure signal was then analyzed using Beatscope Software (TNO-TPD, Biomedical
Instrumentation) to estimate other cardiovascular variables. Stroke volume (SV) was estimated using
the Modelflow method [33,34], and cardiac output (CO) was calculated as the product of HR and SV,
whilst total peripheral resistance (TPR) was determined by dividing the mean arterial BP (MAP) by the
CO. Additionally, arterial pressure was measured in the right arm by an electro-sphygmomanometer
(Omron Healthcare, Kyoto, Japan) to corroborate the BP measurements from the Portapres® device.
IBI and SAP values extracted from Portapres® device were used for subsequent baroreflex sensitivity
(BRS) analysis [31].
2.4. Data Analysis
Mean values of BP (SAP, DAP and MAP), other hemodynamic variables (SV, CO and TPR) and
BRS and HRV indexes were calculated from the last 5 min of the 10-min period during supine rest and
from the entire 5 min of the squat stand test (SST).
Beat-by-beat SAP and IBI values were used to assess cardiac baroreflex sensitivity (BRS). SAP and
IBI data were linearly interpolated and resampled at 2 Hz for spectral and transfer function analysis
(TF). Under resting conditions, TF of gain, phase and coherence between spontaneous oscillations
in SAP and IBI were calculated in accordance with the work of Zhang et al. [35], i.e., 0.05–0.15 Hz
for the low frequency (LF) range. During SST (performed at 0.05 Hz) TF gain, phase and coherence
were calculated across a specific frequency (SF) range (i.e., 0.031–0.078 Hz). Cardiac BRS was also
assessed with the sequence method [36]. The sequence method is based on the identification of at least
three consecutive beats (sequence) in which a defined increase (or decrease) in SAP is followed by
a defined increase (or decrease) in the IBI. Only sequences with a minimum correlation coefficient
of 0.85 were accepted. Positive and negative sequences were averaged to obtain a representative
value of cardiac baroreflex sensitivity (BRSseq). To better represent BP control in the increasing and
decreasing directions, mean gain values of positive (BRSSeq+) and negative (BRSSeq−) sequences were
also computed separately.
As described and independently, R–R intervals obtained using the Polar RS800CX heart rate
monitor were uploaded to the Polar Precision Performance software (Polar, Kempele, Finland) and
then exported as text files. HRV analysis was performed using Kubios HRV software (Version 2.1,
Biosignal Analysis and Medical Imaging Group, Kuopio, Finland [37]). Signal artifacts were filtered
by means of a moderate error correction filter. All the time series of R–R intervals showed low noise
(identified errors <5%). As the physiological significance of several HRV indexes is still disputed [38],
only indexes of parasympathetic modulation were calculated in the time domain (square root of
the sum of successive differences between adjacent normal R–R intervals squared; RMSSD) and in
the frequency-domain high-frequency spectral power (HF, 0.15–0.4 Hz), calculated by Fast Fourier
Transform (FFT) [39]. The respiratory rate was neither controlled nor recorded. However, on an
individual basis, we systematically checked that the respiratory sinus arrythmia peak fell within the
HF band. All recordings were consistent in this regard.
2.5. Statistical Analysis
Data are presented as mean ± SD. The normal distribution of the data was verified with the
Shapiro–Wilk test. If data were not normally distributed, natural logarithm transformation (Ln) was
applied to obtain a normal distribution and to allow parametric statistical comparisons. All the
variables were normally distributed after this procedure. Two-tailed unpaired t-tests were used to
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compare running times during the run between the two groups. A two-way (time (pre vs. post) ×
group (men vs. women)) repeated measures analysis of variance (ANOVA) followed by Holm–Sidak
post hoc analyses was performed to assess the effects of run and group on all other variables. A p-value
of <0.05 was considered statistically significant.
3. Results
The height (p < 0.001) and weight (p < 0.001) of women (164.8 ± 6.1 cm and 58.2 ± 7.5 kg,
respectively) were significantly reduced compared to men (178.3± 6.7 cm and 75.0± 8.3 kg, respectively).
Both women and men were normal-weight according to their body mass index values, the values being,
nevertheless, significantly higher in women than in men (21.4 ± 1.8 vs. 23.6 ± 2.3 kg·m−2 for women
and men, respectively, p = 0.012). No significant difference in age (p = 0.110) was observed (39.1 ± 9.3
and 45.7 ± 10.5 years for women and men, respectively). The
.
VO2max (p = 0.018) and MAS (p = 0.034)
of women (46.8 ± 6.8 mL·kg−1·min−1 and 13.7 ± 2.2 km·h−1, respectively) were significantly lower than
for men (51.3 ± 8.5 mL·kg−1·min−1 and 15.8 ± 2.2 km·h−1, respectively). The speeds associated with VT1
(p = 0.049) and VT2 (p = 0.041) were significantly lower for women (10.6 ± 1.5 and 11.8 ± 1.8 km·h−1,
respectively) than for men (11.7 ± 1.2 and 13.4 ± 1.5 km·h−1, respectively).
Hemodynamic variables and indexes of ANS function during supine rest are presented in Figure 1
(bottom) and Table 1. Before the run, women exhibited a significantly lower SAP, MAP, CO and SV
compared to men, whilst other hemodynamic variables were not different (i.e., HR and TPR). They also
exhibited significantly higher Ln-RMSSD, Ln-HF and HFnu, as well as significantly lower coherence-LF
from transfer function analysis.
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Figure 1. Mean ± SD Systolic (SAP; black bars) and diastolic (DAP; white bars) blood pressures
before (Pre) and after (Post) the 21-km run in men (left panels) and women (right panels) in supine
position (up panels) and during the squat stand test (bottom panels). SAP = systolic arterial blood
pressure, DAP = diastolic arterial blood pressure; pre = before the half-marathon run; post = after the
half-marathon run; * = significantly different from pre.
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Table 1. Hemodynamic and neuro-hormonal variables before (Pre) and after (Post) the 21-km run in
women and men in supine position.
REST
Women Men
Pre Post Pre Post
Hemodynamics
HR bpm 60.2 ± 10.5 68.3 ± 10.9 * 60.4 ± 7.8 74.4 ± 9.0 *
SV mL 78 ± 21 75 ± 21 97 ± 18 # 75 ± 20 *
CO L/min 4.7 ± 1.6 5.1 ± 1.8 5.9 ± 0.9 # 5.7 ± 1.7
SAP mmHg 118 ± 12 110 ± 6 126 ± 13 # 115 ± 9 *
DAP mmHg 61 ± 13 59 ± 7 68 ± 7 65 ± 8
MAP mmHg 79 ± 12 76 ± 5 87 ± 6 # 81 ± 9 *
TPR mmHg perL·min−1 1.19 ± 0.51 1.06 ± 0.54 0.90 ± 0.17 0.91 ± 0.42
Heart Rate Variability
IBI ms 1029 ± 179 904 ± 152 * 1010 ± 127 819 ± 103 *
Ln-RMSSD ms 3.94 ± 0.64 3.61 ± 0.64 * 3.43 ± 0.34 # 2.91 ± 0.34 *,#
Ln-HF ms2 6.51 ± 1.14 5.99 ± 1.53 * 5.61 ± 0.78 # 4.40 ± 0.94 *,#
HFnu 52 ± 14 41 ± 14 * 27 ± 12 # 24 ± 13 *,#
Transfer Function Analysis
Gain-VLF ms mmHg−1 5.1 ± 1.5 6.0 ± 2.9 4.7 ± 1.5 4.8 ± 1.7
Gain-LF ms mmHg−1 8.7 ± 6.1 9.8 ± 8.8 8.1 ± 2.7 5.7 ± 2.5 *
Gain-HF ms mmHg−1 2.43 ± 0.49 2.35 ± 0.85 2.11 ± 0.26 1.77 ± 0.46 #
Phase-VLF rads 0.10 ± 1.10 0.03 ± 0.71 −0.17 ± 0.67 0.06 ± 0.71
Phase-LF rads −0.59 ± 0.38 −0.49 ± 0.56 −0.75 ± 0.28 −0.61 ± 0.25
Phase-HF rads 0.08 ± 0.48 −0.06 ± 0.36 −0.16 ± 0.27 −0.31 ± 0.19 #
Coh-VLF 0.47 ± 0.08 0.53 ± 0.16 0.47 ± 0.10 0.53 ± 0.05
Coh-LF 0.44 ± 0.16 0.46 ± 0.17 0.58 ± 0.09 # 0.54 ± 0.15
Coh-HF 0.40 ± 0.18 0.44 ± 0.17 0.46 ± 0.13 0.45 ± 0.15
Sequence Method
n seq+ 4 ± 2 4 ± 3 5 ± 3 8 ± 5 *,#
n seq− 6 ± 3 4 ± 2 6 ± 3 9 ± 5 *,#
BRS-seq+ ms mmHg−1 12.6 ± 10.1 16.3 ± 10.1 11.2 ± 5.7 8.3 ± 3.6 #
BRS-seq− ms mmHg−1 13.7 ± 10.6 19.1 ± 15.4 11.7 ± 7.9 9.2 ± 5.5 #
BRS-seq ms mmHg−1 13.3 ± 9.6 16.5 ± 10.1 11.5 ± 4.7 9.2 ± 4.7 #
HR = Heart beat; SV = Stroke Volume; CO = Cardiac Output; SAP = systolic arterial blood pressure;
DAP = diastolic arterial blood pressure; MAP = Mean arterial blood pressure; TPR = total peripheral resistance;
IBI = inter-beat-interval; RMSSD = square root of the sum of successive differences between adjacent normal R–R
intervals squared; HF = High Frequency; nu = normalized units; VLF = Very Low Frequency; LF = Low Frequency;
Coh = Coherence; n seq = number of sequences; BRS = Baroreflex sensitivity; pre = before the half-marathon run;
post = after the half-marathon run; * = significantly different from PRE; # = different from women; p < 0.05.
Hemodynamic variables and indexes of ANS during SST are presented in Figure 1 (top) and
Table 2. Before the run, no hemodynamic and autonomic variables were different between women and
men, except a significantly lower SV and CO in women.
Absolute running performance was significantly slower amongst women than men (half-marathon
time (p = 0.028) and mean speed (p = 0.024) were 120.1± 19 min and 10.8± 1.6 km·h−1 and 104.4± 13.7 min
and 12.3 ± 1.5 km·h−1 for women and men, respectively). However, when expressed as percentage of
MAS, the speed of their performances was very similar (78.1 ± 4.6 and 78.2 ± 5.4% for women and
men, respectively, p = 0.962). This represented 90 ± 6% and 92 ± 6% of the speed associated with VT2
(p = 0.412) and 101 ± 7% and 105 ± 8% of the speed associated with VT1 (p = 0.199) for women and
men, respectively, without significant differences between the two groups.
No significant differences between groups were observed for both absolute (p = 0.102) and relative
weight loss (p = 0.376) after the half-marathon (−0.94 ± 0.58 kg (−1.51 ± 0.61%) and −1.13 ± 0.67 kg
(−1.62 ± 0.78%) and for women and men, respectively).
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Table 2. Hemodynamic and baroreflex function variables before (Pre) and after (Post) the 21-km run in
women and men during squat stand test.
Squat Stand Test
Women Men
Pre Post Pre Post
Hemodynamics
HR bpm 84 ± 10 95 ± 11 * 81 ± 11 101 ± 8 *
SV mL 61 ± 23 66 ± 16 96 ± 18 # 58 ± 20 *
CO L/min 5.1 ± 2.2 6.0 ± 1.4 7.6 ± 1.8 # 5.6 ± 2.1 *
SAP mmHg 130 ± 16 125 ± 23 143 ± 28 116 ± 17 *
DAP mmHg 72 ± 14 64 ± 21 72 ± 13 71 ± 18
MAP mmHg 91 ± 14 84 ± 19 95 ± 17 85 ± 19
TPR mmHg perL.min−1 1.18 ± 0.63 1.10 ± 0.52 0.84 ± 0.24 0.93 ± 0.45
Heart Rate Variability
IBI ms 737 ± 87 655 ± 85 * 766 ± 97 605 ± 50 *
Ln-RMSSD ms 3.92 ± 0.56 3.53 ± 0.51 * 3.80 ± 0.39 3.14 ± 0.33 *,#
Ln-HF ms2 6.47 ± 1.10 5.45 ± 1.11 6.22 ± 1.06 * 4.96 ± 0.78 *
HFnu 9 ± 8 5 ± 3 9 ± 13 6 ± 3
Transfer Function Analysis
Gain-SF ms mmHg−1 3.72 ± 2.43 3.76 ± 2.49 3.82 ± 1.98 2.36 ± 1.00 *
Phase-SF rads −0.69 ± 0.39 −0.97 ± 0.32 * −0.93 ± 0.39 −0.96 ± 0.37
Coh-SF 0.62 ± 0.20 0.64 ± 0.10 0.70 ± 0.10 0.72 ± 0.11
Sequence Method
n seq+ 12 ± 2 13 ± 3 11 ± 6 9 ± 5
n seq− 15 ± 3 14 ± 3 13 ± 4 14 ± 3
BRS-seq+ ms mmHg−1 7.03 ± 5.11 8.09 ± 7.58 4.79 ± 1.24 5.11 ± 2.80
BRS-seq− ms mmHg−1 6.13 ± 4.32 5.74 ± 3.65 3.61 ± 1.12 4.25 ± 2.15
BRS-seq ms mmHg−1 6.65 ± 4.31 6.83 ± 5.34 4.00 ± 1.09 4.66 ± 2.04
HR = Heart beat; SV = Stroke Volume; CO = Cardiac Output; SAP = systolic arterial blood pressure;
DAP = diastolic arterial blood pressure; MAP = Mean arterial blood pressure; TPR = total peripheral resistance;
IBI = inter-beat-interval; RMSSD = square root of the sum of successive differences between adjacent normal R–R
intervals squared; HF = High Frequency; nu = normalized units; VLF = Very Low Frequency; LF = Low Frequency;
Coh = Coherence; n seq = number of sequences; BRS = Baroreflex sensitivity; * = significantly different from PRE;
# = different from women; p < 0.05.
During supine rest after the 21-km race, HR was significantly increased in both groups (Table 1).
SAP, MAP and SV significantly decreased in men only. Ln-RMSSD significantly decreased in both
groups, with the values for women remaining significantly higher than for men. Ln-HF significantly
decreased in men only, with Ln-HF being significantly lower than in women. In women only, HFnu
significantly decreased. The number of positive and negative sequences significantly increased in men
only, with the values being significantly higher than in women. On the contrary, during supine rest
after the run, the baroreflex sensitivity assessed by the sequence method was significantly higher in
women than in men. Additionally, cardiac BRS assessed by the transfer function method showed a
significant decreased in men only (gain-LF).
During SST after the race, the mean HR significantly increased in both groups (Table 2). SAP, SV
and CO decreased in men only. Ln-RMSSD and Ln-HF significantly decreased in both groups. Gain
BRS-SF significantly decreased in men only. Phase BRS-SF significantly increased in women only.
4. Discussion
The aim of the present study was to compare the cardiovascular and autonomic changes triggered
by a competitive 21-km run (half-marathon) in women and men. We hypothesized that women would
show greater autonomic and cardiovascular alterations, but the results did not confirm our hypothesis.
The main finding was that women did not exhibit significant post-exercise hypotension and cardiac
BRS impairment during supine rest or during a dynamic task challenging the BP control via orthostatic
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stress (5-min squat stand test), maintaining a significantly higher parasympathetic nervous activity
than men after a competitive half-marathon.
In our study, women were smaller and lighter than men. Accordingly, they exhibited smaller SV
and CO at rest before the half-marathon (Table 1) [21]. We also observed a lower MAP in women.
This is in accordance with repeated observations suggesting that women have a lower prevalence of
hypertension, and tend to have lower BP than men, until the age of menopause [20,22,40,41], when
the incidence of these processes accelerate and reach those of men rapidly [22]. The ANS activity
may partly explain this observation since women tend to have lower muscle sympathetic nerve
activity [42]. Also, higher indexes of cardiac vagal control have been reported in both young and
middle-age women [21,25,29,43], as in the present study. Hence, our results are in accordance with
the observation that women typically display greater parasympathetic control of HR than men at
rest [20,21]. Several studies have reported that compared to men, resting cardiac BRS is decreased
in young women [20,44–46], but this finding is not universal, as other studies have also reported
no differences [20,30,47,48], such as is the present study (Table 1). While cardiac BRS is linked to
parasympathetic activity, increased HRV indexes do not necessarily means increased cardiac BRS, as
already observed [49]. Taken together, these data are in line with the view that men and women display
different autonomic and cardiovascular profiles at rest, with the latter showing higher parasympathetic
activity and lower BP levels.
In addition to the parasympathetically mediated difference, men and women differ in terms
of anthropometric and body composition characteristics as well as hormonal status, which confers
physiological advantages upon men in sport performance [50]. However, the sex dimorphism in
performance depends on the sport discipline and competition duration. Men may benefit from their
larger body size, muscle mass and greater strength, and maximal anaerobic and aerobic capacity
particularly during sports involving high power output. Conversely, the sex difference in performance
is smallest in long distance disciplines, as observed with ultramarathon run for example [30]. While in
the present study the same relative speed (≈78% of MAS) was observed in both groups, men completed
the 21-km faster than women due to their higher MAS. For both groups, the observed performance
was in the range of expected values for half-marathon participants of similar training levels (e.g., [51]).
The longer exercise duration for women resulted in a similar weight loss (that could be used as a
rough estimation of hydration status), which was in the range of typical weight loss observed with a
half-marathon race [31].
As expected in response to the race, the two groups showed a significant increase in HR together
with a significant reduction in HRV parasympathetic-derived indexes, both at rest and during SST
(Table 2). Despite this reduction, parasympathetic indexes remained significantly higher in women
than in men (Table 2), suggesting that even after strenuous exercise, healthy pre-menopausal trained
women still exhibit cardioprotective autonomic profiles [52].
On the other hand, significantly decreased SV, SAP and MAP (i.e., post-exercise hypotension)
were observed in men only, highlighting dissimilar post-exercise cardiovascular responses between
sexes. The selective decrease in SV has been reported after 60 min of cycling at 60% of peak oxygen
uptake [27], but not after longer endurance-type exercise such as an ultramarathon [30]. Together
with methodological considerations (i.e., posture, time after exercise, method used to assess SV),
this discrepancy is likely due to the relative intensity maintained during the exercise (the lower the
longer the exercise), and to the possibility (or not) of water ad libitum. As well, a significant decrease
in SAP and MAP at rest (i.e., post-exercise hypotension [53]) was observed in men only, and was
accompanied by a decrease in cardiac BRS (both transfer function and sequence method) and an
increase in the number of positive and negative sequences to compensate for the reduced BRS slope.
Interestingly, during the dynamic task (SST), significant systolic blood pressure reduction was observed
despite absence of significant reduction in BRS. It implies that the mechanisms triggering post-exercise
hypotension are different during resting and dynamic conditions. Unfortunately, the present data
do not allow us to give a satisfactory explanation of this phenomenon. Further studies are thus
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required to specifically address the question of a different post-exercise regulation at rest and under
dynamic conditions.
Cardiac BRS is important in regulating BP, and post-exercise alterations depend upon the intensity
of the prior exercise. For instance, 30 min of exercise at 65% of HRmax leads to cardiac BRS
improvement [54], whilst high-intensity (>85% HRmax) and maximal aerobic exercises (conducted to
exhaustion) may result in decreased post-exercise cardiac BRS, which generally recovers within 60
min of exercise termination [55,56]. In the range of intensities used in our study, likely above >85%
HRmax and at an average intensity of 78% of MAS and 90% of the speed associated to the second
ventilatory threshold maintained for 100–120 min, cardiac BRS responses may be more variable due to
dual autonomic control of the heart or thermal influences on HR [53]. Unfortunately, only men were
involved in these previous studies, and for instance, Senitko et al. [27] did not evaluate cardiac BRS in
their comparison of sedentary and trained women and men after 1 h of cycling. No sex differences
in cardiac BRS have been reported after ultra-endurance exercise (135 ± 50 km, over 28 ± 9 h) [30]
but in that case, the nature of the exercise stimuli is very different from the present study (beyond
the important duration, the intensity for such race is low (e.g., [57])). Hence, to date, sex differences
in post-exercise cardiac BRS responses have been poorly studied and do not specifically relate to
endurance exercise [49,58], making comparison with the existing literature difficult. Due to the scarce
evidence available, the combination of exercise intensity and duration that can trigger a significant sex
influence on post-exercise BRS requires further study and clarification. Yet our work suggests, for the
first time, dissimilar post-exercise cardiac BRS responses between men and women.
The limitations of the present study relate to its design. The design of this study is cross-sectional,
and we cannot exclude that factors other than sex were responsible for our observations, such as
different characteristics linked to training history. Also, the specific organization of this study did
not allow us to recruit more participants and limited the sample size [59]. Despite this limit, most
of the observed significant differences were associated with the appropriate statistical power of 80%.
Previously, work that reported sex differences following laboratory-based investigations used similar
sample sizes (e.g., [25,30]), and we do not believe this factor impacted our results, although we cannot
exclude the possibility of a type II error. However, confirmation of our results with a larger sample
size is mandatory.
Also, this study limits our ability to obtain detailed information about women’s menstrual cycle
phases and contraceptive habits. It is known that exercise recovery depends on menstrual cycle
phase, at least within muscle [60]. However, previous work suggests that cycle phase does not affect
BRS as well as the gain around the operating point in young women [20]. Hence, it is possible that
cardiovascular and ANS evaluations in the present study may have been different in the women in other
phases of their menstrual cycle. However, this would have introduced more variability into the data,
and since we were able to demonstrate significant group differences in key outcomes, we do not believe
this impacted our results. Age also matters in SAP control, since the higher vagal activity seen in young
women tends to disappear with increasing age [22]. The similar baroreflex responses between men and
women observed after ultratrail running [30] were amongst 45 years-old women, an age group slightly
older than ours (39 years-old). Beyond this age-difference, the history of exercise training needs to be
better quantified as well. Indeed, different training characteristics could lead to different ANS [61] and
blood pressure [62] responses. Also, this study may have benefitted from a better method of evaluating
the race characteristics, including the evaluation of pacing strategy (i.e., positive or negative split), race
load (using, e.g., Edward’s TRIMP [63]), cardiac strain (using, e.g., the Physioflow device [64]) and
hydration status, to assess any potential differences in hemodynamic variables. Finally, a difference
of up to 19% (0.3 L·min−1) has been reported when comparing Modelflow to thermodilution [65],
and thus, an alternative method could have been used, at least to calibrate the Modelflow. Because of
theses limits and although we did measure some mechanistically relevant variables like catecholamines,
we have not focused on the mechanisms and further studies are needed to confirm our observations
and examine any underlying mechanisms.
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5. Conclusions
Overall, our results showed that a competitive 21-km run did not trigger post-exercise hypotension
during supine rest or during a dynamic task designed to challenge BP control mechanisms via orthostatic
stress (5-min repeated squat stand test) in women. Despite a significant reduction post half-marathon,
women were able to maintain a significantly higher parasympathetic nervous activity compared to
men, with a preserved cardiac baroreflex sensitivity. Our results support the idea that aerobically
trained healthy premenopausal women are able to cope with the stresses of competitive running and
continue to display a cardioprotective autonomic profile after strenuous aerobic exercises. Further
research investigating the sex differences in post-exercise autonomic and cardiovascular responses
(with special regard to the hemodynamic determinants of post-exercise hypotension and baroreflex
responses to various exercises) is needed.
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